Realtime Oncology
Treatment Calculator®

ESMO 2020

Digital Therapy Planning

In the field of oncology, we have entered the era of digital therapy, in which artificial intelligence is already directly involved in the planning of oncology therapies.


Warning: file_get_contents(): SSL operation failed with code 1. OpenSSL Error messages: error:14090086:SSL routines:ssl3_get_server_certificate:certificate verify failed in /var/www/clients/client4/web220/web/site/themes/rt/functions.php on line 65

Warning: file_get_contents(): Failed to enable crypto in /var/www/clients/client4/web220/web/site/themes/rt/functions.php on line 65

Warning: file_get_contents(https://www.realtimeoncology.com/site/uploads/2020/05/np_artificial-intelligence_1701154_000000.svg): failed to open stream: operation failed in /var/www/clients/client4/web220/web/site/themes/rt/functions.php on line 65

At this year’s virtual ESMO, we present the performance and utility results of our digital drug-assignment system (RealTime Oncology Treatment Calculator, RTO) in the precision oncology of pediatric cancer based on whole-exome sequencing (WES).

In the poster we will present data on the ratio of actionable findings, demonstrating the performance of our artificial intelligence-based oncology software in identifying registered targeted treatment options for pediatric cancers. Regarding the utility, we will show whether the digital drug-assignment score of the RTO correlates with the clinical decisions of our virtual molecular tumor board of experts.

View our poster VIEW OUR ABSTRACT Find our virtual booth

Frequently Asked Questions

  • How digital therapy planning is different from the known molecular-based decision support systems?

    Using the results of molecular diagnostics and bioinformatics, the Calculator uses real-time Aggregated Evidence Level (AEL) algorithm to rank the evidences in real time during digital therapy planning, thus supporting the oncologist's decision.

  • How digital therapy planning is different from other known AI-based oncology decision support systems?

    The RTO not only collects evidence based on molecular profiles, but also ranks them based on the AEL algorithm, providing unique assistance in digital therapy planning. The RTO - if the molecular information allows - analyzes the entire molecular profile, not just individual molecular targets.

  • What tests are required to use the RTO?

    The RTO does not perform molecular diagnostic tests, but uses the results of previous diagnostic tests in the digital therapy planning (i.e.: molecular pathology findings, VCF file, report, etc.). The Calculator also provides support for what molecular tests are recommended based on the available medical history and pathological results, and our partner network can assist in their implementation if required.

  • How can I use the RTO?

    The RTO is the result of the continuous development work of a multidisciplinary development team, and its full use requires special training.

    If you would like to apply to your oncology cases, please, contact us!

Apply for training

 

  • Would you like to try it?

    If you have an oncology case or you already have a completed molecular diagnostic report, give it a try and contact us!

    With the help of your own case, we will introduce you to the process of digital therapy planning.

Contact us